heme degradation HMOX1
Selected indexed studies
- Ferroptosis as a target for protection against cardiomyopathy. (Proc Natl Acad Sci U S A, 2019) [PMID:30692261]
- Cellular senescence-associated gene IFI16 promotes HMOX1-dependent evasion of ferroptosis and radioresistance in glioblastoma. (Nat Commun, 2025) [PMID:39890789]
- Iron-loaded cancer-associated fibroblasts induce immunosuppression in prostate cancer. (Nat Commun, 2024) [PMID:39426954]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Ferroptosis as a target for protection against cardiomyopathy. (2019) pubmed
- Cellular senescence-associated gene IFI16 promotes HMOX1-dependent evasion of ferroptosis and radioresistance in glioblastoma. (2025) pubmed
- Iron-loaded cancer-associated fibroblasts induce immunosuppression in prostate cancer. (2024) pubmed
- Exploring the efficacious constituents and underlying mechanisms of sini decoction for sepsis treatment through network pharmacology and multi-omics. (2024) pubmed
- LncRNA RGMB-AS1 inhibits HMOX1 ubiquitination and NAA10 activation to induce ferroptosis in non-small cell lung cancer. (2024) pubmed
- Heme oxygenase-1 protects cells from replication stress. (2024) pubmed
- HMOX1 as a potential drug target for upper and lower airway diseases: insights from multi-omics analysis. (2025) pubmed
- Heme exporter FLVCR1a regulates heme synthesis and degradation and controls activity of cytochromes P450. (2014) pubmed
- Heme degradation and human disease: diversity is the soul of life. (2002) pubmed
- Heme catabolism by tumor-associated macrophages controls metastasis formation. (2021) pubmed